M&A · Healthcare · Dental Equipment & Supplies
ArchiMed to acquire ZimVie Inc.
Announced Jul 21, 2025 · Closed Oct 20, 2025
Deal value$730MEV $730M
Premium125.0%To unaffected price
EV / Adj. EBITDA18.9x1.6x EV / Revenue
ConsiderationAll cash$19.00 per share
Transaction
- Acquirer
- ArchiMed
- Target
- ZimVie Inc. (ZIMV)
- Buyer type
- Private equity
- Offer price per share
- $19.00
- Enterprise value
- $730M
- Status
- Closed Oct 20, 2025
Deal protections
- Break fee (target pays)
- $20.3M · 2.8%
- Reverse fee (buyer pays)
- $40.5M · 5.5%
- Go-shop
- Go-shop
- Financing
- No financing condition
Advisors
- To the acquirer
- UBS
- To the target
- Centerview
- Centerview fee
- $20.0M
Sector context · Healthcare
- Comparable deals
- 95 in the prior 24 months
- Premium
- 125.0% vs. 66.5% sector median
- EV / Adj. EBITDA
- 18.9x vs. 13.8x sector median
- Break fee
- 2.8% vs. 3.4% sector median
Timeline
- AnnouncedJul 21, 2025
- Proxy filedAug 15, 2025
- Definitive proxySep 2, 2025
- Shareholder voteOct 10, 2025
- ClosedOct 20, 2025
Valuation · fairness opinions
Trading comparables$14.00$18.75
Precedent transactions$17.00$21.25
Discounted cash flow$15.75$22.00
Premiums paid$10.50$14.00
Analyst price targets$9.00$16.00
Offer $19.00
Implied value per ZimVie Inc. share by analysis, from Centerview · DCF discount rate 11.5%–13.5%.